Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 49.55% is 15% above its 5-year average of 43.25%, near the high end of its 5-year range (0.70%–64.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.19% below its 12-month average of 53.39%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
49.55%
DEBT TO ASSETS RATIO AVG TTM
53.39%
DEBT TO ASSETS RATIO AVG 3Y
44.30%
DEBT TO ASSETS RATIO AVG 5Y
43.25%
DEBT TO ASSETS RATIO AVG 10Y
20.65%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.19%
CURRENT VS 3Y AVG
+11.83%
CURRENT VS 5Y AVG
+14.56%
CURRENT VS 10Y AVG
+139.92%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 87 covered companies
CURRENT VS SECTOR MEDIAN
+16985.02%
vs the sector median at left
PDS Biotechnology Corporation
Market Cap
$11.79M
Debt to Assets Ratio
49.55%
TTM Avg
53.39%
3Y Avg
44.30%
5Y Avg
43.25%
Market Cap
$438.82M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.18B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.23B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.06B
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.40B
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.43B
Debt to Assets Ratio
0.43%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | 49.55% | 53.39% | 44.30% | 43.25% |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | 0.10% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $492.43M | 0.66% | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | 0.38% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | 0.44% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 0.59% | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.00B | 0.01% | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 0.29% | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | 0.43% | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.84B | 0.21% | N/A | N/A | N/A |
Debt/Assets
49.5%
Debt/Equity
-1.22
Current Ratio
0.57
Interest Coverage
-5.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 49.55% |
| 2026-03-31 | 64.31% |
| 2025-12-31 | 55.50% |
| 2025-09-30 | 51.77% |
| 2025-06-30 | 45.80% |
| 2025-03-31 | 40.32% |
| 2024-12-31 | 48.12% |
| 2024-09-30 | 47.03% |
| 2024-06-30 | 40.30% |
| 2024-03-31 | 34.94% |
| 2023-12-31 | 40.16% |
| 2023-09-30 | 41.28% |
| 2023-06-30 | 36.89% |
| 2023-03-31 | 34.34% |
| 2022-12-31 | 30.48% |
| 2022-09-30 | 31.20% |
| 2022-06-30 | 0.70% |
| 2022-03-31 | 0.75% |
| 2021-12-31 | 0.73% |
| 2021-09-30 | 0.73% |
| 2021-06-30 | 0.71% |
| 2021-03-31 | 2.10% |
| 2020-12-31 | 1.98% |
| 2020-09-30 | 1.85% |
| 2020-06-30 | 3.31% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 4.91% |
| 2019-03-31 | 4.45% |
| 2018-12-31 | 0.08% |
| 2018-09-30 | 0.08% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 27.28% |
| 2017-12-31 | 22.09% |
| 2017-09-30 | 20.09% |
| 2017-06-30 | 17.89% |
| 2017-03-31 | 15.10% |
| 2016-12-31 | 13.48% |
| 2016-09-30 | 12.71% |
| 2016-06-30 | 3.72% |
| 2016-03-31 | 3.88% |
| 2015-12-31 | 3.95% |
| 2015-09-30 | 10.09% |
| 2015-06-30 | 9.36% |
| 2014-12-31 | 16.38% |
